Ten years ago today, on the 28 August 2013, the Scottish Dementia Research Consortium was established at the Surgeon’s Hall, Edinburgh.

The SDRC was created to enable greater co-ordination by pooling the resources, experience and expertise of the wide-ranging and multi-disciplinary dementia research community in Scotland. The aim of this was to build relationships with funding bodies, governmental organisations, and each other, to grow funding and career opportunities for academics in the field. See the video below which was produced when the SDRC first launched.

The SDRC grew steadily, in the first 5 years its members formed meaningful collaborations and connections. It gained 200-300 members and the SDRC Annual Conference quickly became a key date in the calendar, becoming the primary networking and learning opportunity for dementia researchers, showcasing the wonderful work ongoing across disciplines. The SDRC Executive Committee, who oversee the SDRC’s operations and strategy, has been made up of world leading researchers from the beginning and were key in building the organisation and ensuring fulfills its purpose. 

Here are just a few of examples of what the SDRC has done in the past 10 years: 

  • Events for networking and learning opportunities
  • Annual mapping of the Scottish dementia research landscape, which allows the Executive Committee to benchmark activity and identify areas for development
  • Producing an Annual Report which promotes ongoing dementia research activity and celebrates success
  • Highlighting the work of researchers and research participants by publishing blogs on the SDRC website
  • Promoting the research and playing a key role in translating research findings into practice. By working closely with policy-makers, care providers, and other stakeholders we help ensure that research findings are incorporated into policy and practice, and that people with dementia and their families are able to benefit from the latest research.
  • We have supported early career researchers through schemes such as the mentorship programme and webinar series
  • Keeping members up to date with the latest news in dementia and brain health in our mailing list
  • Supporting funding schemes, for example: awarding small grants to help early career researchers during COVID; working with Alzheimer Scotland to deliver their Student Research Programme; providing support to the Scottish Neurological Research Fund 

Now, as we approach the end of the first decade of the SDRC, we have a lot to celebrate, but we know we still have a lot to do. We now have almost 1100 members and we will continue to listen to them and work together to nurture and grow dementia and brain health research in Scotland.

 

Read more SDRC Latest

Neuroprogressive and Dementia Research Network Conference 2022

This year's Neuroprogressive and Dementia Network (from NHS Research Scotland) Annual Conference will be day focused on those most impacted by research outcomes, and an opportunity to learn from their experiences to improve the research landscape. It will bring...

Treating dementia, what’s next and how do we get there?

On the 21st September 2021, World Alzheimer's Day, Alzheimer Scotland held their annual conference. It was a virtual event which was attended by people with dementia, carers, practitioners and other members of the public from all over Scotland.  In the afternoon...

Research Strategy Oversight Board Chair: Henry McLeish

The Scottish Dementia Research Consortium, Brain Health Scotland and Alzheimer Scotland are delighted to announce the appointment of Henry McLeish as the Chair of the Scottish Brain Health and Dementia Research Strategy Oversight Board.  In July 2021, the SDRC,...

The launch of the SDRC Annual Report 2020/21

The SDRC Annual Report 2020/21, launched at the SDRC Annual Conference 2021 on Wednesday 16th June. It outlines what research has been ongoing in dementia and brain health research in Scotland in the past 12 months. Of course, it heavily features the impact COVID has...

Aducanumab: Approval of new Alzheimer’s disease drug explained

Aducanumab: Dr Terry Quinn explains approval of new Alzheimer's disease drug  SDRC Executive Committee member, Dr Terry Quinn, Terry takes us through all the important facts behind the recent announcement by the FDA in the US to approve aducanumab for the treatment of...

Alzheimer Disease International Clinician Survey

This year Alzheimer's Disease International has commissioned McGill University, Montreal, Canada to produce this year's World Alzheimer Report on diagnosis, as well as the 2022 World Alzheimer Report on post-diagnostic support. The first of three surveys is now ready...

Take part in a research study: Remote Cognitive Testing Survey

The University of Oxford are looking for volunteers from Scotland to take part in a survey about the Impact of COVID-19 on cognitive testing  The Translational Neuropsychology Lab at the University of Oxford, are investigating the impacts of COVID-19 UK lockdown on...

Professor John Starr: A tribute

We're deeply saddened to hear that Professor John Starr has passed away. Prof Starr supported our work for many years as an Alzheimer Scotland Trustee, and as the Director of the Alzheimer Scotland Dementia Research Centre at the University of Edinburgh....

Alzheimer Scotland Centre for Policy and Practice (ASCPP) 2021 Annual Report

The Alzheimer Scotland Centre for Policy and Practice (ASCPP) has launched its Annual Celebration Report, 2021. It has a focus on education success and also features their work in applied research and their support of evidence based policy and practice work. We are...

Launch of the SDRC Early Career Researcher Group

The SDRC are very excited to announce the launch of our Early Career Researcher (ECR) Group. This group are made up of ECRs from research institutions across Scotland, representing all dementia and brain health disciplines. Their purpose is to advise the SDRC...